Power morcellator for uterine fibroid removal not linked to cancer risk
the ONA take:
According to new findings published in the journal JAMA Oncology, researchers have found that the risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morcellator is used to remove fibroids in the uterus is low.
Before the U.S. Food and Drug Administration issued a black-box warning on the devices last November that the morcellator could spread and worsen an undetected cancerous uterine tumor, power morcellators were commonly used during minimally invasive surgery to remove uterine fibroids.
Uterine fibroids, which are non-cancerous growths in the uterine wall, are very common, but sometimes need to be removed when they cause pelvic pain and heavy menstrual bleeding. Treatment options include a hysterectomy to remove the uterus or surgery to remove the fibroids.
For the study, researchers identified 42,000 American women who had fibroids removed between 2006 and 2012, 3,200 of which were removed with power morcellators.
Of those, three were found to have uterine cancer, meaning the odds of developing uterine cancer after uterine fibroid removal was about 1 in 1,000 patients compared with 1 in 528 among women whose fibroid removal did not involve the power morcellators. The researchers note that the findings are reassuring.
Risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morecellator is used to remove fibroids in the uterus is low.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|